Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

Quintiles sets up central laboratory services in Japan

Quintiles Transnational : 27 March, 2008  (Company News)
Quintiles Transnational has reached an agreement with Medca Japan to provide central laboratory services to further extend Quintiles global network of laboratories certified by the College of American Pathologists (CAP).
Quintiles will have its own staff at the CAP-certified Medca Japan laboratory in Saitama, a city in the Greater Tokyo area. The lab will support clinical trials in Japan.

'Recent changes in legislation are allowing Japanese pharmaceutical companies to extend clinical trials normally conducted in Japan to other countries in Asia, but these companies have had difficulty finding central lab services that are harmonised throughout the region,' said Tom Wollman, senior vice president, Quintiles Global Central Laboratories. 'With CAP-certified labs in Beijing, Singapore, Mumbai and now Japan, we can provide well- controlled processes and harmonized testing services throughout the Asia- Pacific region to customers in Japan as well as our multinational customers. This lab, along with all labs in our network, will follow the same standard operating procedures, and data will be available on our QNET database.'

'We have established excellent systems for providing high-quality central laboratory services based on Quintiles' global standard,' said Yoh Narimatsu, president, Quintiles Transnational Japan, a subsidiary of Quintiles Transnational. 'We are determined to continue to increase clinical trials in Japan and provide superior services for our customers through this strategic business alliance.'

Yutaka Kannari, president of Medca Japan Laboratory, said he was pleased that Medca has the capability and the high quality standards necessary to play an important role in the expansion of Quintiles' business in Asia, and he also sees the alliance helping Medca.

'This collaboration with Quintiles will be very helpful for the future success of Medca Japan,' Kannari said. 'We receive more than 30,000 specimens for examination per day, and this relationship will allow us to strengthen out clinical trial services while supporting continued growth of our existing laboratory operations.'

Medca provides a broad range of laboratory services, including biochemical tests as well as endocrine testing, tumour marker testing, drug-level testing, immunology testing and microbiological testing. The laboratory has undertaken specimens for examination from about 4,000 medical institutions throughout Japan.

Alan Ong, vice president and general manager, Quintiles Labs Asia, who will give technical guidance, and Narimatsu, who will provide his expertise on the Japan market, will manage the relationship with Medca within Quintiles.

CAP certification follows a site inspection. The accreditation is intended to improve Patient safety by advancing the quality of pathology and laboratory services through education, setting standards and ensuring laboratories meet or exceed regulatory requirements.
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo